Literature DB >> 16729317

Step-by-step progress toward understanding the hepatitis C virus RNA helicase.

David N Frick1.   

Abstract

Helicases are a ubiquitous class of enzymes involved in nearly all aspects of DNA and RNA metabolism. Despite recent progress in understanding their mechanism of action, limited resolution has left inaccessible the detailed mechanisms by which these enzymes couple the rearrangement of nucleic acid structures to the binding and hydrolysis of ATP. Observing individual mechanistic cycles of these motor proteins is central to understanding their cellular functions. Here we follow in real time, at a resolution of two base pairs and 20 ms, the RNA translocation and unwinding cycles of a hepatitis C virus helicase (NS3) monomer. NS3 is a representative superfamily-2 helicase essential for viral replication, and therefore a potentially important drug target. We show that the cyclic movement of NS3 is coordinated by ATP in discrete steps of 11 +/- 3 base pairs, and that actual unwinding occurs in rapid smaller substeps of 3.6 +/- 1.3 base pairs, also triggered by ATP binding, indicating that NS3 might move like an inchworm. This ATP-coupling mechanism is likely to be applicable to other non-hexameric helicases involved in many essential cellular functions. The assay developed here should be useful in investigating a broad range of nucleic acid translocation motors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729317      PMCID: PMC3571624          DOI: 10.1002/hep.21200

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate an inchworm mechanism.

Authors:  S S Velankar; P Soultanas; M S Dillingham; H S Subramanya; D B Wigley
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Uncoupling DNA translocation and helicase activity in PcrA: direct evidence for an active mechanism.

Authors:  P Soultanas; M S Dillingham; P Wiley; M R Webb; D B Wigley
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

3.  Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase.

Authors:  Victor Serebrov; Anna Marie Pyle
Journal:  Nature       Date:  2004-07-22       Impact factor: 49.962

4.  The functional interaction of the hepatitis C virus helicase molecules is responsible for unwinding processivity.

Authors:  Mikhail K Levin; Yuh-Hwa Wang; Smita S Patel
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

5.  Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.

Authors:  D Liu; Y S Wang; J J Gesell; D F Wyss
Journal:  J Mol Biol       Date:  2001-11-30       Impact factor: 5.469

6.  Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.

Authors:  N Yao; P Reichert; S S Taremi; W W Prosise; P C Weber
Journal:  Structure       Date:  1999-11-15       Impact factor: 5.006

7.  The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3).

Authors:  C L Tai; W K Chi; D S Chen; L H Hwang
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.

Authors:  J A Suzich; J K Tamura; F Palmer-Hill; P Warrener; A Grakoui; C M Rice; S M Feinstone; M S Collett
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  General methods for analysis of sequential "n-step" kinetic mechanisms: application to single turnover kinetics of helicase-catalyzed DNA unwinding.

Authors:  Aaron L Lucius; Nasib K Maluf; Christopher J Fischer; Timothy M Lohman
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

10.  Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo.

Authors:  A A Kolykhalov; K Mihalik; S M Feinstone; C M Rice
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

View more
  2 in total

1.  Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.

Authors:  Austin N Spratt; Fabio Gallazzi; Thomas P Quinn; Christian L Lorson; Anders Sönnerborg; Kamal Singh
Journal:  Expert Opin Ther Pat       Date:  2021-04-21       Impact factor: 6.674

Review 2.  Other inhibitors of viral enzymes and functions.

Authors:  H Zimmermann; G Hewlett; H Rübsamen-Waigmann
Journal:  Handb Exp Pharmacol       Date:  2009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.